New Moscow pricing system heralds changes in Russia
This article was originally published in Clinica
The Moscow City government has introduced a new pricing system for medical devices and medicinal products. The system is mainly aimed at medical devices sold in pharmacies, a spokesperson for Roche in Moscow told Clinica. It does not cover diagnostic products.
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.